A nuclear factor Y (NFY) site positively regulates the human CD34 stem cell gene

Blood

Volumn 94, Issue 11, 1999, Pages 3772-3780

  Radomska, Hanna S ^b   Satterthwaite, Anne B ^b   Taranenko, Natalie ^b   Narravula, Sailaja ^b   Krause, Diane S ^b   Tenen, Daniel G ^a  

^a HARVARD INSTITUTES OF MEDICINE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CD34 ANTIGEN; NUCLEAR FACTOR; TRANSCRIPTION FACTOR;

ARTICLE; BINDING SITE; ELECTROPHORETIC MOBILITY; GENE EXPRESSION REGULATION; HEMATOPOIESIS; HUMAN; HUMAN CELL; NUCLEOTIDE SEQUENCE; ONCOGENE C MYB; PRIORITY JOURNAL; PROMOTER REGION;

EID: 0033485858     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v94.11.3772     Document Type: Article

References (62)

1. Krause DS, Fackler MJ, Civin CI, May WS: CD34: Structure, biology, and clinical utility. Blood 87:1, 1996
2. Burn TC, Satterthwaite AB, Tenen DG: The human CD34 hematopoietic stem cell antigen promoter and a 3′ enhancer direct hematopoietic expression in tissue culture. Blood 80:3051, 1992
3. He XY, Antao VP, Basila D, Marx JC, Davis BR: Isolation and molecular characterization of the human CD34 gene. Blood 79:2296, 1992
4. Krause DS, Kapadia SU, Raj NB, May WS: Regulation of CD34 expression in differentiating M1 cells. Exp Hematol 25:1051, 1997
5. Yamaguchia Y, Tenen DG, Suda T: Functional characterization of the promoter for the gene encoding murine CD34. Biochem Biophys Acta 1350:141, 1997
6. May G, Enver T: Targeting gene expression to haemopoietic stem cells: A chromatin-dependent upstream element mediates cell type-specific expression of the stem cell antigen CD34. EMBO J 14:564, 1995
7. Radomska HS, Satterthwaite AB, Burn TC, Oliff IA, Tenen DG: Multiple control elements are required for expression of the human CD34 gene. Gene 222:305, 1998
8. Melotti P, Calabretta B: Ets-2 and c-Myb act independently in regulating expression of the hematopoietic stem cell antigen CD34. J Biol Chem 269:25303, 1994
9. Melotti P, Ku D-H, Calabretta B: Regulation of the expression of the hematopoietic stem cell antigen CD34: Role of c-myb. J Exp Med 179:1023, 1994
10. Perrotti D, Melotti P, Skorski T, Casella I, Peschle C, Calabretta B: Overexpression of the zinc finger protein MZF1 inhibits hematopoietic development from embryonic stem cells: Correlation with negative regulation of CD34 and c-myb promoter activity. Mol Cell Biol 15:6075, 1995
11. Morris JF, Rauscher FJ, Davis BR, Klemsz M, Xu D, Tenen DG, Hromas R: The myeloid zinc finger gene, MZF-1, regulates the CD34 promoter in vitro. Blood 86:3640, 1995
12. Chodosh LA, Baldwin AS, Carthew RW, Sharp PA: Human CCAAT-binding proteins have heterologous subunits. Cell 53:11, 1988
13. Hooft van Huijsduijnen R, Li XY, Black D, Matthes H, Benoist C, Mathis D: Co-evolution from yeast to mouse: cDNA cloning of the two NF-Y (CP-1/CBF) subunits. EMBO J 9:3119, 1990
14. Mantovani R: A survey of 178 NF-Y binding CCAAT boxes. Nucleic Acids Res 26:1135, 1998
15. Currie RA: Biochemical characterization of the NF-Y transcription factor complex during B lymphocyte development. J Biol Chem 273:18220, 1998
16. Marziali G, Perrotti E, Ilari R, Testa U, Coccia EM, Battistini A: Transcriptional regulation of the ferritin heavy-chain gene: The activity of the CCAAT binding factor NF-Y is modulated in heme-treated Friend leukemia cells and during monocyte-to-macrophage differentiation. Mol Cell Biol 17:1387, 1997
17. Marziali G, Perrotti E, Ilari R, Coccia EM, Mantovani R, Testa U, Battistini A: The activity of the CCAAT-box binding factor NF-Y is modulated through the regulated expression of its a subunit during monocyte to macrophage differentiation: Regulation of tissue-specific genes through a ubiquitous transcription factor. Blood 93:519, 1999
18. Katula KS, Wright KL, Paul H, Surman DR, Nuckolls FJ, Smith JW, Ting JP, Yates J, Cogswell JP: Cyclin-dependent kinase activation and S-phase induction of the cyclin B1 gene are linked through the CCAAT elements. Cell Growth Differ 8:811, 1997
19. Huang CC, Hou Y, Woods LK, Moore GE, Minowada J: Cytogenetic study of human lymphoid T-cell lines derived from lymphocytic leukemia. J Natl Cancer Inst 53:655, 1974
20. Klein G, Lindahl T, Jondal M, Leibold W, Menezes J, Nilsson K, Sundstrom C: Continuous lymphoid cell lines with characteristics of B cells (bone-marrow-derived), lacking the Epstein-Barr virus genome and derived from three human lymphomas. Proc Natl Acad Sci USA 71:3283, 1974
21. Dexter TM, Allen TD, Scott D, Teich NM: Isolation and characterisation of a bipotential haematopoietic cell line. Nature 277:471, 1979
22. Nordeen SK: Luciferase reporter gene vectors for analysis of promoters and enhancers. Biotechniques 6:454, 1988
23. Innis MA, Gelfand DH, Sninsky JJ, White TJ: PCR Protocols. A Guide to Methods and Applications. San Diego, CA, Academic, 1990
24. Zaret KS, Liu JK, DiPersio CM: Site-directed mutagenesis reveals a liver transcription factor essential for the albumin transcriptional enhancer. Proc Natl Acad Sci USA 87:5469, 1990
25. Smith LT, Hohaus S, Gonzalez DA, Dziennis SE, Tenen DG: PU.1 (Spi-1) and C/EBPα regulate the granulocyte colony-stimulating factor receptor promoter in myeloid cells. Blood 88:1234, 1996
26. Pahl HL, Burn TC, Tenen DG: Optimization of transient transfection into human myeloid cell lines using a luciferase reporter gene. Exp Hematol 19:1038, 1991
27. Bradford MM: A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248, 1976
28. Radomska HS, Shen CP, Kadesch T, Eckhardt LA: Constitutively expressed Oct-2 prevents immunoglobulin gene silencing in myeloma x T cell hybrids. Immunity 1:623, 1994
29. Maity SN, Sinha S, Ruteshouser EC, de Crombrugghe B: Three different polypeptides are necessary for DNA binding of the mammalian heteromeric CCAAT binding factor. J Biol Chem 267:16574, 1992
30. Mantovani R, Pessara U, Tronche F, Li XY, Knapp AM, Pasquali JL, Benoist C, Mathis D: Monoclonal antibodies to NF-Y define its function in MHC class II and albumin gene transcription. EMBO J 11:3315, 1992
31. Chen HM, Pahl HL, Scheibe RJ, Zhang D-E, Tenen DG: The Sp1 transcription factor binds the CD11b promoter specifically in myeloid cells in vivo and is essential for myeloid-specific promoter activity. J Biol Chem 268:8230, 1993
32. Zhang D-E, Hetherington CJ, Tan S, Dziennis SE, Gonzalez DA, Chen HM, Tenen DG: Sp1 is a critical factor for the monocytic specific expression of human CD14. J Biol Chem 269:11425, 1994
33. Murre C, Voronova A, Baltimore D: B-cell-and myocyte-specific E2-box-binding factors contain E12/E47-like subunits. Mol Cell Biol 11:1156, 1991
34. Bain G, Maandag ECR, Izon DJ, Amsen D, Kruisbeek AM, Weintraub BC, Krop I, Schlissel MS, Feeney AJ, Vanroon M, Vandervalk M, Teriele HPJ, Berns A, Murre C: E2A proteins are required for proper B cell development and initiation of immunoglobulin gene rearrangements. Cell 79:885, 1994
35. Zhuang Y, Soriano P, Weintraub H: The helix-loop-helix gene E2A is required for B cell formation. Cell 79:875, 1994
36. Saffer JD, Jackson SP, Annarella MB: Developmental expression of Sp1 in the mouse. Mol Cell Biol 11:2189, 1991
37. Chen HM, Ray-Gallet D, Zhang P, Hetherington CJ, Gonzalez DA, Zhang D-E, Moreau-Gachelin F, Tenen DG: PU.1 (Spi-1) autoregulates its expression in myeloid cells. Oncogene 11:1549, 1995
38. Ephrussi A, Church GM, Tonegawa S, Gilbert W: B lineage -Specific interactions of an immunoglobulin enhancer with cellular factors in vivo. Science 227:134, 1985
39. Church GM, Ephrussi A, Gilbert W, Tonegawa S: Cell-type-specific contacts to immunoglobulin enhancers in nuclei. Nature 313:798, 1985
40. Shen CP, Kadesch T: B-cell-specific DNA binding by an E47 homodimer. Mol Cell Biol 15:4518, 1995
41. Yu H, Porton B, Shen LY, Eckhardt LA: Role of the octamer motif in hybrid cell extinction of immunoglobulin gene expression: extinction is dominant in a two enhancer system. Cell 58:441, 1989
42. Ishimaru F, Mari B, Shipp MA: The type 2 CD10/neutral endopeptidase 24.11 promoter: Functional characterization and tissue-specific regulation by CBF/NF-Y isoforms. Blood 89:4136, 1997
43. Brown J, Greaves MF, Molgaard HV: The gene encoding the stem cell antigen, CD34, is conserved in mouse and expressed in haemopoietic progenitor cell lines, brain, and embryonic fibroblasts. Int Immunol 3:175, 1991
44. Yasuda H, Galli SJ, Geissler EN: Cloning and functional analysis of the mouse c-kit promoter. Biochem Biophys Res Commun 191:893, 1993
45. Bucher P: Weight matrix descriptions of four eukaryotic RNA polymerase II promoter elements derived from 502 unrelated promoter sequences. J Mol Biol 212:563, 1990
46. Wright KL, Moore TL, Vilen BJ, Brown AM, Ting JP: Major histocompatibility complex class II-associated invariant chain gene expression is up-regulated by cooperative interactions of Sp1 and NF-Y. J Biol Chem 270:20978, 1995
47. Roder K, Wolf SS, Beck KF, Schweizer M: Cooperative binding of NF-Y and Sp1 at the DNase I-hypersensitive site, fatty acid synthase insulin-responsive element 1, located at -500 in the rat fatty acid synthase promoter. J Biol Chem 272:21616, 1997
48. Milos PM, Zaret KS: A ubiquitous factor is required for C/EBP-related proteins to form stable transcription complexes on an albumin promoter segment in vitro. Genes Dev 6:991, 1992
49. Yu L, Wu Q, Yang CP, Horwitz SB: Coordination of transcription factors, NF-Y and C/EBP beta, in the regulation of the mdr1b promoter. Cell Growth Differ 6:1505,1995
50. Ericsson J, Jackson SM, Edwards PA: Synergistic binding of sterol regulatory element-binding protein and NF-Y to the farnesyl diphosphate synthase promoter is critical for sterol-regulated expression of the gene. J Biol Chem 271:24359, 1996
51. Dooley KA, Millinder S, Osborne TF: Sterol regulation of 3-hydroxy-3-methylglutaryl-coenzyme A synthase gene through a direct interaction between sterol regulatory element binding protein and the trimeric CCAAT-binding factor/nuclear factor Y. J Biol Chem 273:1349, 1998
52. Hasan S, Koda T, Kakinuma M: An upstream NF-Y-binding site is required for transcriptional activation from the hst promoter in F9 embryonal carcinoma cells. J Biol Chem 269:25042, 1994
53. Currie RA: Functional interaction between the DNA binding subunit trimerization domain of NF-Y and the high mobility group protein HMG-I(Y). J Biol Chem 272:30880, 1997
54. Chang ZF, Liu CJ: Human thymidine kinase CCAAT-binding protein is NF-Y, whose A subunit expression is serum-dependent in human IMR-90 diploid fibroblasts. J Biol Chem 269:17893, 1994
55. Roy B, Lee AS: Transduction of calcium stress through interaction of the human transcription factor CBF with the proximal CCAAT regulatory element of the grp78/BiP promoter. Mol Cell Biol 15:2263, 1995
56. Orita T, Shimozaki K, Murakami H, Nagata S: Binding of NF-Y transcription factor to one of the cis-elements in the myeloperoxidase gene promoter that responds to granulocyte colony-stimulating factor. J Biol Chem 272:23216, 1997
57. Li XY, Hooft van Huijsduijnen R, Mantovani R, Benoist C, Mathis D: Intron-exon organization of the NF-Y genes. Tissue-specific splicing modifies an activation domain. J Biol Chem 267:8984, 1992
58. Wright KL, Vilen BJ, Itoh-Lindstrom Y, Moore TL, Li G, Criscitiello M, Cogswell P, Clarke JB, Ting JP: CCAAT box binding protein NF-Y facilitates in vivo recruitment of upstream DNA binding transcription factors. EMBO J 13:4042, 1994
59. Linhoff MW, Wright KL, Ting JP: CCAAT-binding factor NF-Y and RFX are required for in vivo assembly of a nucleoprotein complex that spans 250 base pairs: The invariant chain promoter as a model. Mol Cell Biol 17:4589, 1997
60. Currie RA: NF-Y is associated with the histone acetyltransferases GCN5 and P/CAF. J Biol Chem 273:1430, 1998
61. He X-Y, Cockerill PN, Cen D, Davis BR: Transcriptional regulation and chromatin structure of the human CD34 gene promoter region. Blood 83:1822, 1994
62. Johnson PF, Landschulz WH, Graves BJ, McKnight SL: Identification of a rat liver nuclear protein that binds to the enhancer core element of three animal viruses. Genes Dev 1:133, 1987